title: Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
authors.affiliation: Mycobacteriology Research Center, NRITLD Massih Daneshvari Hospital, Darabad, Niavaran, Tehran, Iran. tabarsi@nritld.ac.ir
authors.forename: Payam
authors.initials: P
authors.lastname: Tabarsi
authors.forename: Parvaneh
authors.initials: P
authors.lastname: Baghaei
authors.forename: Mehdi
authors.initials: M
authors.lastname: Mirsaeidi
authors.forename: Majid
authors.initials: M
authors.lastname: Amiri
authors.forename: Narges
authors.initials: N
authors.lastname: Alipanah
authors.forename: Habib
authors.initials: H
authors.lastname: Emami
authors.forename: Atieh
authors.initials: A
authors.lastname: Novin
authors.forename: Davood
authors.initials: D
authors.lastname: Mansouri
authors.forename: Mohammad R
authors.initials: MR
authors.lastname: Masjedi
authors.forename: Ali A
authors.initials: AA
authors.lastname: Velayati
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology; D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008297:Male; D017828:Rifabutin / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000904:Antibiotics, Antitubercular; D017828:Rifabutin